ALTERITY THERAPEUTICS LTD (PRNAF:OTCMKTS)

$0.35 -0.1 (-22.2222%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 78

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ALTERITY THERAPEUTICS LTD (PRNAF:OTCMKTS) News Sources

Alterity Therapeutics Appoints Highly Experienced Biotech Executive Ann Cunningham to its Board of Directors

17-04-2026

yahoo.com

Alterity Therapeutics Presents New Analysis of ATH434 Phase 2 Trial Data in Late Breaking Science Session of the American Academy of Neurology

22-04-2026

yahoo.com

Alterity Therapeutics Receives Positive FDA Feedback Following Second Type C Meeting on ATH434 Phase 3 Program in Multiple System Atrophy

27-04-2026

yahoo.com

Alterity Therapeutics Releases Appendix 4C – Q3 FY26 Quarterly Cash Flow Report & Corporate Update

30-04-2026

yahoo.com

Alterity Therapeutics to Deliver Presentations at Multiple Medical Conferences in May 2026

07-05-2026

yahoo.com

Alterity Therapeutics Announces Publication Demonstrating the Utility of Quantitative MRI as a Biomarker for Multiple System Atrophy

11-05-2026

yahoo.com

Alterity Therapeutics Data Presentations Support Advancement of ATH434 into Phase 3 in Multiple System Atrophy

19-05-2026

yahoo.com

Alterity Therapeutics Achieves Alignment with U.S. FDA on Pivotal Phase 3 Program for ATH434 in Multiple System Atrophy

09-06-2026

yahoo.com

Alterity Therapeutics to Participate in the Virtual BTIG Biotechnology Conference 2026

21-07-2026

yahoo.com

Alterity Therapeutics Releases Appendix 4C – Q4 FY26 Quarterly Cash Flow Report & Corporate Update

30-07-2026

yahoo.com

ALTERITY THERAPEUTICS LTD (PRNAF:OTCMKTS) Sentiment Trend

0 25 50 75 100 83 79 74 69 87 76 83 77 86 65 17-04-2026 22-04-2026 27-04-2026 30-04-2026 07-05-2026 11-05-2026 19-05-2026 09-06-2026 21-07-2026 30-07-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ALTERITY THERAPEUTICS LTD (PRNAF:OTCMKTS) FAQs

toggle

What is the current price of ALTERITY THERAPEUTICS LTD (PRNAF:OTCMKTS)?

The current price of ALTERITY THERAPEUTICS LTD (PRNAF:OTCMKTS) is $0.35.


toggle

ALTERITY THERAPEUTICS LTD (PRNAF:OTCMKTS) absolute price change since previous trading day?

The absolute price change of ALTERITY THERAPEUTICS LTD (PRNAF:OTCMKTS) since the previous trading day is $-0.1.


toggle

ALTERITY THERAPEUTICS LTD (PRNAF:OTCMKTS) percentage price change since previous trading day?

The percentage price change of ALTERITY THERAPEUTICS LTD (PRNAF:OTCMKTS) since the previous trading day is -22.2222%.


toggle

What is the most recent average sentiment score for ALTERITY THERAPEUTICS LTD (PRNAF:OTCMKTS)?

The most recent average sentiment score for ALTERITY THERAPEUTICS LTD (PRNAF:OTCMKTS) is 78 out of 100.


toggle

What is the most recent average sentiment for ALTERITY THERAPEUTICS LTD (PRNAF:OTCMKTS)?

The most recent sentiment for ALTERITY THERAPEUTICS LTD (PRNAF:OTCMKTS) is .


SEC-8K** Filing Available For ALTERITY THERAPEUTICS LTD (PRNAF:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.